ArticleCureus2025
Atypical Presentation of Microscopic Polyangiitis in an Elderly Woman.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microscopic polyangiitis (MPA) is a rare, necrotizing vasculitis that primarily affects small-sized blood vessels, with a predilection for the upper and lower respiratory tract and the kidneys. It is commonly associated with the presence of perinuclear antineutrophil cytoplasmic antibodies (p-ANCA), often targeting myeloperoxidase (MPO), and typically presents with renal impairment, pulmonary symptoms, or systemic features such as fatigue and weight loss. We report the case of a 76-year-old Caucasian woman who presented with anemia, dark stools, and acute kidney injury (AKI) but lacked significant pulmonary symptoms. Her evaluation revealed chronic sinusitis on imaging and pauci-immune necrotizing glomerulonephritis (GN) on kidney biopsy, with perinuclear antineutrophil cytoplasmic antibody (p-ANCA) positivity and limited crescent formation. Despite the absence of overt respiratory or constitutional symptoms, her diagnosis of MPA was confirmed, and she was initiated on rituximab therapy with plans for outpatient rheumatology and nephrology follow-up. This case highlights the importance of considering vasculitis in elderly patients presenting with unexplained renal dysfunction and subtle upper respiratory findings, even in the absence of classic systemic features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.